Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Validation Protocol Approval – V 2.0

Posted on By

SOP for Validation Protocol Approval – V 2.0

Procedure for Validation Protocol Approval

Department Quality Assurance (QA)/Validation/Production
SOP No. SOP/Ointment/118
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the approval process for validation protocols in ointment manufacturing. This ensures that all validation activities are planned, reviewed, and authorized before execution.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA), Validation, and Production departments responsible for reviewing, approving, and managing validation protocols.

3. Responsibilities

  • Validation Officer: Prepares validation protocols and ensures they align with regulatory guidelines.
  • QA Officer: Reviews the protocol for completeness and compliance.
  • Production Supervisor: Confirms protocol feasibility and operational applicability.
  • QA Manager: Approves the protocol before execution.
  • Regulatory Affairs (if applicable): Ensures the protocol meets regulatory requirements.
See also  Ointments: SOP for Process Equipment Calibration in Manufacturing - V 2.0

4. Accountability

The QA and Validation Managers are accountable for ensuring that validation protocols are reviewed, approved, and documented as per GMP, FDA, ICH, and WHO guidelines.

5. Procedure

5.1 Validation Protocol Preparation

  • The Validation Officer drafts the validation protocol, including:
    • Purpose and scope of validation
    • Equipment, materials, and methods used
    • Critical parameters and acceptance criteria
    • Testing methodology and sampling plan
    • Approval section for signatures
  • The draft protocol is circulated to QA and Production for initial review.

5.2 Review and Revisions

  • QA reviews the protocol to
ensure compliance with regulatory requirements.
  • Production confirms the feasibility of executing the protocol under routine conditions.
  • Any necessary revisions are incorporated, and the document is updated.
  • 5.3 Approval Process

    • Once finalized, the validation protocol is submitted for approval.
    • Signatures are obtained from:
      • Validation Officer
      • Production Supervisor
      • QA Manager
      • Regulatory Affairs (if applicable)
    • QA retains a master copy of the approved protocol.

    5.4 Execution and Monitoring

    • The approved protocol is executed as per the defined procedures.
    • QA monitors the validation study to ensure adherence to the protocol.
    • Any deviations are recorded and assessed.

    5.5 Validation Report Preparation

    • Upon completion of the validation study, a final report is prepared.
    • The report includes:
      • Summary of test results
      • Deviation records (if any)
      • Conclusion and recommendations
    • The final validation report undergoes the same approval process as the protocol.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • FDA – Food and Drug Administration
    • ICH – International Council for Harmonisation

    7. Documents

    • Validation Protocol Template (Annexure-1)
    • Validation Approval Log (Annexure-2)

    8. References

    • ICH Q7 – Good Manufacturing Practice Guide
    • WHO Guidelines for Validation of Manufacturing Processes
    • US FDA Guidance on Process Validation

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Validation Protocol Template

    Section Description
    Objective Defines the purpose of validation
    Scope Details the areas covered
    Acceptance Criteria Defines critical parameters
    Testing Methodology Describes tests performed

    Annexure-2: Validation Approval Log

    Validation Protocol ID Approval Date Approved By Comments
    VAL-2025-001 01/02/2025 QA Manager Approved without changes
    VAL-2025-002 05/02/2025 QA Manager Minor revisions incorporated

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    See also  Ointments: SOP for Preparing and Reviewing Standard Operating Procedures - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Creams: SOP for Reconciliation of Dispensed Materials – V 2.0
    Next Post: Capsule: SOP for Preformulation Studies for Capsule Dosage Forms – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version